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Medication related osteonecrosis of the jaw in minipig model: parameters to develop a 
macroscopic, radiologic and microscopic grading scheme 
                          
Objectives: To devise a macroscopic, radiological, and histological scale for assessing 
pathological changes associated with medication-related osteonecrosis of the jaw in a 
minipig model. 
Materials and methods: Medication-related osteonecrosis of the jaw was induced in 
Göttingen minipigs by weekly intravenous administration of bisphosphonate (zoledronic 
acid) combined with a tooth extraction procedure. Controls either did not receive 
zoledronic acid or did not undergo tooth extraction. After 20 weeks, minipigs were 
euthanized and underwent computed tomography and micro-computed tomography 
scanning. The mandible underwent additional histological examination. 
Results: The most consistent macroscopic findings in animals that had developed 
bisphosphonaterelated osteonecrosis of the jaw (BRONJ) were necrotic, denuded bone, 
and formation of fistula and pus. Under radiological examination, impaired extraction 
socket healing, decrease in attenuation of bone beneath the extraction site, and periosteal 
reaction were observed. Under histological examination, demineralization of the 
extracellular bone matrix, denuding of bone, and osteonecrosis were recorded. 
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Medikamenten-assoziierte Kiefernekrose beim Minipigmodell:Parameter zur Entwicklung 
eines makroskopischen, radiologischen und mikroskopischen Graduirungsschemas 
                          
Ziele: Entwicklung eines mikroskopischen, radiologischen und 
histologischen Bewertungssystems zur Beurteilung von pathologischen 
Kieferveränderungen im Zusammenhang mit medikamentenbedingter 
Osteonekrose beim Minipigmodell. 
Material und Methode: Eine medikamentenbedingte Osteonekrose des Kiefers wurde bei 
Göttinger Minipigs durch wöchentliche intravenöse Verabreichung von Bisphosphonat 
(Zoledronat) in Kombination mit einer Zahnextraktion induziert. Den Kontrollgruppen 
wurden entweder keine Zoledronat injiziert oder wurden keiner 
Zahnextraktion unterzogen. Nach 19 Wochen wurden die Minipigs 
euthanasiert und es wurden Computer- und Mikrocomputertomographien 
durchgeführt. Die Unterkiefer wurden zusätzlich histologisch untersucht. 
Resultate: Der einheitliche makroskopische Befund 
bei den Tieren, die eine Bisphosphonate-assoziierte Kiefernekrose 
entwickelt haben, waren nekrotisch entblösste Knochen und eitrige 
Fistelbildungen. In den radiologischen Untersuchungen wurden 
Beeinträchtigung der Wundheilung der Zahnfächer, Rückgänge der 
Knochendichte unter den Extraktionsstellen und Reaktionen 
der Knochenhaut beobachtet. In den histologischen 
Untersuchungen wurden die demineralisation der Knochenmatrix, 
Denudation vom Zahnfleisch so wie Knochennekrose verzeichnet. 
Rückschlüsse/Ergebnisse: Diese Parameter haben als Grundlage 
gedient, um ein Bewertungssystem für die Bisphosphonate-assoziierte 
Kiefernekrose beim Minipig zu entwickeln. 
Bisphosphonate, BRONJ, Minipig
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a b s t r a c t
Objectives: To devise a macroscopic, radiological, and histological scale for assessing pathological
changes associated with medication-related osteonecrosis of the jaw in a minipig model.
Materials and methods: Medication-related osteonecrosis of the jaw was induced in G€ottingen minipigs
by weekly intravenous administration of bisphosphonate (zoledronic acid) combined with a tooth
extraction procedure. Controls either did not receive zoledronic acid or did not undergo tooth extraction.
After 20 weeks, minipigs were euthanized and underwent computed tomography and micro-computed
tomography scanning. The mandible underwent additional histological examination.
Results: The most consistent macroscopic findings in animals that had developed bisphosphonate-
related osteonecrosis of the jaw (BRONJ) were necrotic, denuded bone, and formation of fistula and
pus. Under radiological examination, impaired extraction socket healing, decrease in attenuation of bone
beneath the extraction site, and periosteal reaction were observed. Under histological examination,
demineralization of the extracellular bone matrix, denuding of bone, and osteonecrosis were recorded.
Conclusion: These parameters were used to develop a scoring system for grading BRONJ.
© 2019 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights
reserved.
1. Introduction
Bisphosphonates (BPs) are anti-resorptive drugs widely used to
treat osteoporosis, Paget's disease, malignant hypercalcemia, or
resorptive skeletal alterations associated with metastatic malig-
nancies (Sambrook and Cooper, 2006; Hatoum et al., 2008). While
being very effective in restoring bone density (Major et al., 2001), a
rare but severe clinical condition called bisphosphonate-related
osteonecrosis of the jaw (BRONJ), also known as medication-
related osteonecrosis of the jaw (MRONJ), is observed during
treatment with these otherwise well tolerated drugs (Wang et al.,
2003; Marx, 2003; Migliorati, 2003).
BRONJ was first observed in 2003 (Wang et al., 2003; Marx,
2003; Migliorati, 2003) and is currently only described by anam-
nestic and clinical features. The American Society for Bone and
Mineral Research definition (Khosla et al., 2007) adopted by the
American Association of Oral and Maxillofacial Surgeons (Ruggiero
et al., 2009) defines it as involving: (a) the presence of exposed
bone in the oral cavity for a period that exceeds 8 weeks; (b) a
positive BP drug history; and (c) no prior irradiation to the head and
neck region. This definition suggests BP treatment as a risk factor
for BRONJ, but to date the importance of BP and its underlying
pathogenesis is still under discussion (Novince et al., 2009; Kumar
and Sinha, 2013; Cheung and Seeman, 2010). For this reason, a large
animal tooth extraction model using G€ottingen minipigs (Pautke
et al., 2012; Otto et al., 2017) was established to largely represent
the human situation.
Since the full extent of pathological changes related to MRONJ is
not always detectable in clinical examination, computed
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tomography (CT) is increasingly playing a role in screening,
detecting, staging, and monitoring the patients (Torres et al., 2012;
Hutchinson et al., 2010; Arce et al., 2009; Hamada et al., 2014). As it
is critically important to know the differences and similarities be-
tween animal models and clinical patients, careful examination of
radiological findings in minipigs, and their comparison with find-
ings from patients, is warranted.
Histopathology is crucial for understanding pathological pro-
cesses accompanying diseases. To better understand MRONJ, it is
important to carry out careful histopathological examinations of
animal models, and to correlate these with clinical findings to
provide a clinically applicable assessment.
The aim of this study was to establish a scale to allow repro-
ducible assessment of clinical, radiological, and histopathological
findings in a minipig tooth extraction model, and to correlate these
with the clinical manifestation of MRONJ in humans. The animal
outcomes were previously published (Otto et al., 2017). This paper
focuses on the development of a scoring system that could then be
used to unify reporting in future BRONJ studies.
2. Materials and methods
In order to develop this scoring system, a number of radiological
and histological parameters to be investigated across the different
groups were defined by the authors. These parameters were chosen
because they were relatively easy to establish. Based on the results,
those parameters demonstrating a clear difference between ani-
mals that did develop MRONJ and those that did not were included
in the scoring system.
2.1. Methods of obtaining data
All procedures during the study were carried out in an AAALAC-
accredited facility, in accordance with the Swiss laws governing
animal welfare, and were approved by the cantonal and federal
Animal Welfare Commissions of the official veterinary authorities
(Authorization Number 03_2012). Acclimatization, housing, and
feeding were conducted as previously published (reference 13).
Twelve female G€ottingen minipigs (18e21 months;
39.1 ± 4.4 kg) were randomly assigned to one of three groups.
Group 1 (n ¼ 3) had only bisphosphonate administration; group 2
(n ¼ 6), tooth extraction and bisphosphonate administration; and
group 3 (n ¼ 3), only tooth extraction. Zoledronic acid (ZOL) was
administered intravenously to the bisphosphonate groups
(0.05 mg/kg, once a week) through the whole duration of the study
(20 weeks), under sedation (ketamine (15 mg/kg), midazolam
(0.5 mg/kg), and azaperon (2 mg/kg) d all intramuscular).
After 11 weeks of ZOL injections (for group 2), tooth extraction
was performed. All animals were fasted 24 h prior to surgery and
premedicated, as described above. Induction was achieved with an
intravenous injection of propofol (3e5 mg/kg). Animals were than
intubated (armored endotracheal tube) and isoflurane (Et(Iso)
1e1.5%) in 0.6e1 l/min of oxygen and air was administered to
maintain anesthesia.
For analgesic purposes, carprofen (4 mg/kg intravenously) was
administered before the beginning of extraction. A local nerve block
of mandibular and maxillary nerve branches at the extraction
location was performed using lidocaine 2% and bupivacain 0.5%,
with 1:200,000 adrenaline solution.
Unilateral extraction of four premolar (PM) teeth was per-
formed. Using a set of different-sized elevators, the marginal par-
adont of each tooth was freed and the tooth was mobilized until
movement. PM2 (mandible and maxilla) and PM4 (mandible only)
were split into two parts in the transverse plane using a high-speed
instrument. PM4 (maxilla only) was split along the fissures into
three parts, in a star-shaped pattern (one palatinal root and two
buccal roots). The fragments were carefully mobilized and extrac-
ted. Analgesia was maintained using buprenorphine (0.02 mg/kg
intramuscularly) for the first 24h postoperatively, fentanyl patches
(50 mg/h) for the first 3 days postoperatively, and carprofen (4 mg/
kg intramuscularly) 5 days postoperatively. The extraction side was
evaluated on a weekly basis by means of visual inspection, and
scored according to a BRONJ scoring scale described by Ruggiero
et al. (2009). After 20 weeks from the beginning of the study, all
animals were euthanized with an overdose of pentobarbital,
injected via the auricular vein.
Clinical CT scans were acquired immediately after euthanasia.
The scanner (SOMATOM Emotion 6, Siemens, Erlangen, Germany)
was operated with a tube voltage of 130 kVp and tube current of
125 mA; the acquired images had an in-plane resolution of 0.5 mm
and a slice thickness of 0.63 mm, and were reconstructed with a
sharp convolution kernel (H70s).
Animals were necropsied and mandibles (cut in half d left/
right) were scanned again using a microCT scanner (XtremeCT,
Scanco Medical AG) operated at 60 kV and 900 mA, with 750 pro-
jections and 200 ms acquisition time in a 126 mm field of view. The
slices were reconstructed across an image matrix size of
1536  1536 voxels, with a nominal voxel size of 82 mm.
For histological analyses the left-side mandible with PM4
extraction and the right-side mandible without PM4 extraction
were fixed in 70% methanol, trimmed, and cut along the sagittal
plane with a diamond-blade saw (Exact, Norderstedt, Germany).
The lingual half of the tissue, was transferred to xylene, embedded
in methylmethacrylate (MMA), and further cut in consecutive
sections with a thickness of approximately 300e500 mm. The slides
were then glued onto opaque plexiglas holders, ground down to
approximately 175e250 mm thickness, and stained with Giemsa-
Eosin (Fig. 1b). Before mounting and staining, contact radiogra-
phies of the sections were taken using high-resolution technical
films (D4 Structurix DW ETE, Agfa) and a cabinet X-ray system
(Model No. 43855A, Faxitron X-Ray Corporation), applying the
following settings: 20 kV for 40 sec, no filter, 56 cm source-to-
image distance.
2.2. Methods of evaluation
The criteria used for clinical scoring throughout the study are
listed in Table 1.
Clinical observations were recorded weekly, under sedation, by
means of visual inspection of the oral cavity.
All CT scans were assessed using a commercially available
computer program (Osirix, Switzerland). Hounsfield units (HU),
bone mineral density (BMD), and volumetric measurements were
computed using the software's ‘region of interest’ (ROI) tools.
A semi-quantitative and quantitative grading scheme was
developed to assess radiological and histological changes associ-
ated with MRONJ.
The following parameters were evaluated from CT scans of
mandibles: periosteal reaction; soft tissue swelling; empyema;
healing of extraction socket; mean attenuation of trabecular bone
area under PM4, M1, and M2; periodontal ligament space of PM4
and M1; total bone volume; and bone mineral density (BMD) of
mandible between PM3 and M1, and between PM2 and M3
(Table 2).
Semi-quantitative light microscopic analysis, using a grading
scheme (grades 0e5), was performed on the left-sided tooth
extraction sites of the mandibular PM4.
Among others, the following parameters were analyzed and
graded: inflammation of gingiva, periodontium, or of the pulp of
adjacent teeth (gingivitis, periodontitis, pulpitis); inflammation of
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Fig. 1. Ranking of selected histopathological tissue changes according to a five-point scale (grades 0e5). Methanol-fixed, undecalcified, MMA-embedded, Giemsa-eosin-stained
mandibular tissue sections from minipigs treated with zoledronate (except samples A, D, G, J, which are of untreated animals and show typical background changes). The left-hand
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the bone and bone marrow of the jaw (osteomyelitis); pus accu-
mulation in the canalis mandibularis/sinus maxillaris (empyema);
presence of Giemsa-positive bacterial colonies (infection); pres-
ence of osteoblasts on the trabecular surface (bone formation);
presence of Howship lacunae on the trabecular surface, with or
without presence of osteoclasts (osteolysis); foci of n > 5 empty
osteocytic lacunae (osteonecrosis); and incomplete gingival
epithelial wound closure of the extraction site (gingival ulceration
without/with exposed denuded bone (characterized by deminer-
alization of bone matrix) (Table 3).
3. Results
All animals that received zoledronic acid developed symptoms
associated with MRONJ.
3.1. Macroscopic changes
In animals that developed MRONJ, a gradual increase in disease
stage was observed and clinical macroscopic findings, including
gingivitis, exposed necrotic bone, infection, purulent discharge,
fistula formation, abscess formation, and soft tissue swelling, were




Left and right mandible CT scans were evaluated and a variety of
pathological changes were observed. One of themost striking was a
periosteal reaction: minipigs that developed MRONJ showed
marked to massive periosteal and endosteal reaction at the corpus
mandibulae. This was located not only near the extraction side, but
also on the other side of the jaw, and was also observed in animals
that were exposed to bisphosphonate but did not undergo tooth
extraction. Soft tissue swelling visible under these scanning con-
ditions was strongly associated with periosteal reaction/calcifica-
tion, and both phenomena were observed at a similar rate.
3.2.2. Empyema (pus in the canalis mandibularis) was present in
most of the animals that developed MRONJ
Healing of the extraction socket was markedly impaired in all
animals that received zoledronic acid, but in none of the animals
from the control group (tooth extraction only). Mean attenuation
values for trabecular bone were measured at different locations
(PM4, M1, M2) near the extraction site. Some of the animals
column shows changes of low severity (grade 1), the center column those of moderate severity (grade 3), and the right-hand column those of high severity, characteristically
observed in MRONJ (grade 4). Panels,AeC, gingival ulceration (bar 1 cm; inset bar 200 mm). Panel A: (grade 1): note the small, focused disruption of the mucosal basal membrane
in direct proximity to food material (see inset) and accompanied with moderate inflammatory cell infiltration of the submucosa but not of the underlying bone stock. Panel B:
(grade 3): Note the multifocal mucosal disruption, accompanied with severe inflammatory cell infiltration of the submucosa and of the underlying bone stock. Panel C: (grade 4):
note the severe mucosal discontinuity leading to orally denuded bone, demineralization of extracellular bone matrix, colonization with bacterial oral flora (inset), and marked
inflammatory cell infiltration of the bone stock. Panels DeF, osteonecrosis: (bar 200 mm; inset bar 50 mm). Panel D: (grade 1): note the single focus of >5 empty osteocytic lacunae
(inset); the rest of the bone stock visible is vital, with living osteocytes remaining in the lacunae. Panel E: (grade 3): a large percentage of the lacunae of the bone area shown are
empty (inset). Panel F: (grade 4): in the area shown, all osteocytic lacunae are empty; note the irregular shape of the empty lacunae (inset). Panels GeI, osteolysis: (bar 200 mm;
inset bar 50 mm). Panel G: (grade 1): note the focused presence of a few osteoclasts forming semilunar-shaped Howship lacunae (inset); the vast majority of the bone surface is
occupied by osteoblasts. Panel H: (grade 3): the bone surface is irregular and largely occupied by osteoclasts (inset). Panel I: (grade 4): the bone surface is very irregular with many
osteoclasts (inset), with no osteoblasts visible. Panels JeL, osteomyelitis: (bar length 1 cm; inset bar 50 mm). Panel J: (grade 1): note the presence of a single inflammatory cell focus
in the bone marrow (inset); the rest of the whitish-stained fatty bone marrow shows no changes. Panel K: (grade 3): note the large bone marrow areas filled with blue-stained,
inflammatory cells (inset); in the whitish-stained areas fibrous tissue is predominant. Panel L: (grade 4): nearly all the bone marrow is filled with inflammatory cells and cellular
debris (inset). Panels MeO, bacterial infection: (bar 100 mm, inset bar 10 mm [oil immersion]). Panel M: (grade 1): note the presence of a bacterial colony in the slightly inflamed
bone marrow (Panel M); bacteria have filiform and coccoid morphology (inset). Panel N: (grade 3): note the myriad bacteria on the denuded bone surface and a few micrometers
into the bone; the higher magnification again shows a mixed bacterial population (inset). Panel O: (grade 4): note the very large number of bacterial colonies spreading into deeper
areas of the bone stock. Panels PeR, empyema in the canalis mandibularis: (bar 2 mm; inset bar 20 mm). Panel P: (grade 2): note the presence of pus formed by cellular debris
mixed with coccoid bacteria (inset) in the mandibular canal. Panel Q: (grade 3): note the large amount of pus in the mandibular canal (inset). Panel R: (grade 5): the mandibular
canal is completely filled with pus; multifocal Splendor-Hoeppli granula are observed (inset). Methanol-fixed, undecalcified, MMA-embedded, Giemsa-eosin-stained mandibular
tissue sections from minipigs treated with zoledronate. Panels SeU, periosteal bone proliferation in the corpus mandibulae: (bar 1 mm; inset bar 100 mm). Panel S: (grade 1):
note the periosteal formation of a minimal amount of trabecular bone at the corpus. Panel T: (grade 3): periosteal bone formation (trabecular) reaches nearly the same thickness as
the original cortex (solid). Panel U: (grade 4): note the marked periosteal formation of new bone, all of trabecular type, and the ongoing proliferation characterized by the large
number of cuboid-shaped, active osteoblasts lining the reddish-pink bone matrix, and ovoid-shaped osteocytes entrapped in the matrix (inset).
Table 1
MRONJ stage descriptions (Ruggiero et al., 2014).
At risk category No apparent necrotic bone in patients who have been
treated with either oral or IV bisphosphonates
Stage 0 No clinical evidence of necrotic bone, but non-specific
clinical findings, radiographic changes, and symptoms
Stage 1 Exposed and necrotic bone, or fistulae that extend to bone,
in patients who are asymptomatic and have no evidence of
infection
Stage 2 Exposed and necrotic bone, or fistulae that extend to bone,
associated with infection, as evidenced by pain and
erythema in the region of the exposed bone with or without
purulent drainage
Stage 3 Exposed and necrotic bone or a fistula that extends to bone
in patients with pain, infection, and one or more of the
following: exposed and necrotic bone extending beyond the
region of alveolar bone (i.e. inferior border and ramus in the
mandible, maxillary sinus, and zygoma in the maxilla)
resulting in pathologic fracture; extraoral fistula; oral
antral/oral nasal communication; or osteolysis extending to
the inferior border of the mandible of the sinus floor
Table 2
Radiological grading scheme for semi-quantitative and quantitative scoring: grade
0 ¼ absent, grade 1 ¼ minimal, grade 2 ¼ slight, grade 3 ¼ moderate, grade
4 ¼ marked/severe, grade 5 ¼ massive.
Radiological change Grade
Periosteal reaction 0e5
Soft tissue swelling 0e5
Empyema Presence/absence
Healing of extraction socket Presence/absence
Mean attenuation of area of trabecular
bone directly under M2
HU value
Mean attenuation of area of trabecular
bone directly under M1
HU value
Mean attenuation of area of trabecular
bone directly under PM4
HU value
Periodontal ligament space, M1 mm value
Periodontal ligament space, PM4 mm value
Bone volume of mandible in area
between PM3 and M1
mm3 value
Bone mineral density of mandible in
area between PM3 and M1
(CaHa)g/cm3 value
Bone volume of mandible in area
between PM2 and M3
mm3 value
Bone mineral density of mandible in
area between PM2 and M3
(CaHa)g/cm3 value
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receiving zoledronic acid alone showed lower mean HU values, but
because of the large variation no conclusions could be made. The
mean attenuation value directly under extraction site was always
significantly lower in the group that developed MRONJ, in com-
parison with the control (tooth extraction only) animals, which
received no zoledronic acid (891 ± 119 HU and 1172 ± 199 d HU
mean and SD, respectively).
3.2.3. XtremeCT
A more detailed analysis of some parameters was performed
using microCT scans. Bone volume (BV) and bone mineral density
(BMD) were assessed in the area surrounding the PM4 extraction
site, and in a larger area between PM2 andM3. An increased BVwas
associated with animals that had developed BRONJ. In the area
surrounding the extraction site there was a significant BMD
decrease in animals that had developed MRONJ. There was a good
correlation (R2 ¼ 0.96) between these findings and the results for
mean attenuation obtained from clinical CT. In the second area,
between PM2 and M3, some of animals that had received zole-
dronic acid showed lower BMD values. Again, however, the varia-
tion prevented conclusions being drawn, suggesting that this is not
a useful diagnostic marker.
3.3. Microscopic changes
The most obvious microscopic change observed was slight to
massive inflammation of bone marrow and bone stock of the jaws
around the extraction sites. The inflammationwas characterized by
an infiltration of mixed inflammatory cells (chronic osteomyelitis).
This profound inflammation of the jaw was not only present in the
medullary area, but also in form of pus accumulation in the
maxillary sinus, as well as in the mandibular canal (empyema),
which were exclusively found in animals treated with zoledronic
acid with or without tooth extraction. Additional inflammationwas
recordedmore superficially in the gingiva and periodontium, in the
form of diffuse or focal (micro abscesses) cell infiltration, and in the
pulp cavity of adjacent teeth (pulpitis) in animals of all groups.
These changes were often accompanied by plant material, origi-
nating from food in the oral cavity. The deep as well as the super-
ficial inflammations were associatedwith the presence of moderate
to large amounts of bluish-stained Giemsa-positive bacterial col-
onies (infection), multifocally present in the bone marrow and
mandibular canal, as well in and on the gingival epithelium and at
the bone surface. Furthermore, the mandibulary empyema some-
times included deposition of sulfur granules (Splendor-Hoeppli
material), which is morphologically characteristic of infection by
Actinomyces spp. In this context, it is important to mention that
superficial gingivitis, along with bacteria, was also recorded in
control animals (not treated with zoledronic acid). However, the
slight to massive inflammation of the bone marrow and mandib-
ular canal was only recorded in the two groups treated with zole-
dronic acid, even in the absence of concurrent iatrogenic tooth
extraction.
Markedly reduced bone formation was recorded microscopi-
cally in the bone stock, featuring very low numbers of osteoblasts
lining the bone trabeculi. Alongside this, a marked increase in bone
resorption was recorded, characterized by an irregular trabecular
surface lining, showing deep indentations (Howship lacunae). Both
changes were more pronounced in animals treated with zoledronic
acid, and led to a marked reduction in bone density, readily visible
through macroscopic observation of the stained slides and to the
naked eye on contact radiographs. Most of the lacunae were empty,
however, large, multifocal, multinuclear osteoclasts were seen at
these degradation zones. This indicated ongoing active bone
degradation by osteoclasts. Another characteristic change at the
bone stock was the multifocal, patchy-to-diffuse presence of empty
osteocytic lacunae d the microscopic hallmark of osteonecrosis.
However, the mineralized extracellular matrix of these trabeculi
showed no obvious signs of degradation. In contrast, minimal-to
moderate-grade demineralization of bone matrix was recorded at
the bone surface of the empty tooth extraction sites exclusively in
all animals treated with zoledronic acid and that had undergone
tooth extraction. In these cases, the denuded bone exposed to the
oral cavity showed brownish discoloration and destruction of the
mineralized bone matrix. In contrast, animals only treated with
zoledronic acid, showed complete epithelial coverage and absence
of bone demineralization.
4. Discussion
This study assessed multiple macroscopic, radiological, and
histological parameters in animals that did or did not develop
MRONJ-associated changes after bisphosphonate administration.
From each of the three study groups, a few easy-to-perform and
clinically relevant parameters were chosen (Table 4) to devise a
scoring system. This scoring system can be used to design and
monitor studies aimed at therapy and preventionmodels. Results of
the studies can be compared with already existing databases and
templates. The system provides information about a set of estab-
lished methods and can make studies more effective and compa-
rable with each other.
Table 3
Microscopic grading scheme for semi-quantitative light microscopic scoring (*concomintant presence of these two hallmark parameters together defines BRONJ): grade
1 ¼ minimal, grade 2 ¼ slight, grade 3 ¼ moderate, grade 4 ¼ marked/severe, grade 5 ¼ massive.
Histological change Diagnostic term Grade1
Inflammation of gingiva Gingivitis 0e5
Inflammation of periodontium Periodontis 0e5
Inflammation of tooth root cavities Pulpitis 0e5
Presence of non-viable bone or tooth particles Sequester formation Not graded (P)
Inflammation of bone and bone marrow Osteomyelitis 0e5
Inflammation in canalis mandibularis Empyema 0e5
Presence of Giemsa-positive bacterial colonies Bacterial infection 0e5
Presence of sulfur granules (Splendor-Hoeppli material) Characteristic of Actinomyces spp. 0e5
Number of osteoblasts lining the trabecular surface Bone formation 0e5
Irregular trabecular surface lining (Howship lacunae) with/without presence of osteoclasts Osteolysis 0e5
Presence of empty osteocytic lacunae (foci of n > 5) Osteonecrosis 0e5
Discontinuation of oral mucosa Low-grade gingival erosion/ulceration 1e2
With orally exposed/denuded bone (showing bluish-staining in illumination with fluorescent light) High-grade gingival ulceration* 3e5
Destruction of extracellular matrix* (showing bluish fluorescence of osteolytic areas) Demineralization* 0e5
Trabecular-type new bone formation at the corpus mandibulae Peri- or endosteal bone proliferation 0e5
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MRONJ is associated with high morbidity and adversely affects
patients' quality of life. Authors of a position paper from 2014
urged researchers to perform research using animal models to
validate or establish new treatment or prevention strategies
(Ruggiero et al., 2014). The minipig is a well-established MRONJ
animal model, with advantages over dog, sheep, or rodent models
(Pautke et al., 2012; Otto et al., 2017). The scoring system
described in Table 3 can be used in future studies of MRONJ in
minipig models, to produce more tangible results. Parameters
chosen for this system are relatively simple to assess, and can
provide an indication of the severity of the pathological changes
associated with MRONJ.
4.1. Macroscopic parameters
Exposed necrotic bone is a hallmark of macroscopic presenta-
tion of MRONJ. Fistula and abscess formation are often associated
changes (Phal et al., 2007). Purulent discharge is a sign of infection
associated with later stages of MRONJ. Soft tissue swelling and
gingivitis are non-specific, subtle changes associated with
inflammation.
4.2. Clinical parameters
MRONJ is defined as exposed necrotic bone, so this is an obvious
parameter. Fistula that penetrates the jaw was added to MRONJ
definition in a 2014 position paper (Ruggiero et al., 2014). Purulent
discharge is associated with the above two factors, and is evidence
of an infection. Soft tissue swelling and gingivitis are non-specific
and non-dramatic parameters, but they should draw attention
and changes should be noted.
Common radiological signs of human MRONJ include persisting
alveolar sockets after tooth extractions, due to a lack of remodeling,
and a mixed pattern of radiolucent and radiopaque areas. Radio-
lucent areas can occur in the centre of MRONJ lesions, where bone
has already been severely degraded. Areas surrounding the necrotic
bone lesions are often characterized by bone sclerosis, whichmight
be due to the reaction of viable bone. These areas can be large and
might even dominate the radiological representation of MRONJ
(citation 17 and 19).
In our model, persisting alveolar sockets and lower HU values
were found in the area directly beneath the tooth extraction,
coinciding exactly with the main MRONJ area identified histologi-
cally. This is in line with the well-known effects of remodeling
suppression under antiresorptive drugs and bone degradation in
MRONJ lesions, which was also observed in our histological anal-
ysis. However, we did not find the pronounced sclerosis in sur-
rounding bone observed in humans, even though periosteal
swelling and bone proliferationwere already present on the base of
the mandible. The possible explanation of this issue could be that
MRONJ in humans is a slowly developing process, with sclerosis
developing as a consequence of chronic inflammation. In the ani-
mal model, the induction time is more acute because it is not
feasible to wait years to develop long-term chronic inflammatory
foci or chronic osteomyelitis. This results in a difference in how
MRONJ develops. Nevertheless, changes in HU values were our
most significant finding and should be used both for human and
animal studies.
The decrease in cortical bone density was similar in scans per-
formed with clinical CT and microCT. Since it is possible to perform
clinical CT on patients, and there is a good correlation between
BMD and radio intensity (Schreiber et al., 2011), only clinical CT was
included in the scoring, with microCT results used as a control for
our findings. The method used was adopted from another publi-
cation (Hamada et al., 2014) andmodified to fit more to the minipig
model. Empyema formation is a manifestation of infection and is
associated with more severe stages of MRONJ in humans (stages 2
and 3) (Ruggiero et al., 2014). It is therefore important to identify
the severity of the disease.
n this study the MRONJ model was created using intravenous
injections of BPs and tooth extraction, as described by Pautke. In both
BP-treated groups MRONJ-associated changes were similar. In the
group that did not undergo tooth extraction it was not possible to
assess healing of the extraction socket, but cases of spontaneous
MRONJ were observed and were associated with issues such as food
impaction, which were likely to damage the mucosal surface. With
the help of these results, future MRONJ studies in minipigs aimed at
therapy and prevention could have more tangible and consistent
results.
There are some limitations of this study. There are numerous
parameters that could be used in a scoring system. Those used in
this study were selected by the authors, so perhaps there are some
parameters that could better serve this purpose. The chosen pa-
rameters were selected because they had to be relatively easy to
perform and to show a clear difference between animals that did
develop MRONJ and those that did not.
The whole study was carried out using G€ottingen minipigs, so
the authors can only hypothesize that this scoring system is
appropriate for other animal models of MRONJ. It is possible, but
further studies are warranted to support this hypothesis. Never-
theless, the scoring system can provide a basis for more consistent
characterization of future MRONJ studies. Studies that can replicate
these results and similar studies on different species are recom-
mended to increase the scientific basis of these findings.
Histological analysis of MRONJ-related changes helped to better
characterize this relatively new, preclinical, large model for MRONJ.
Preliminary histological evaluation of large animalmodels has been
performed before in dogs (Allen et al., 2010, 2011; Huja et al., 2011),
and in minipigs (Pautke et al., 2012). However, these groups used
decalcified, paraffin-embedded, and hematoxylin-eosin-stained
tissue slides. With changes in the bone tissue predominating in
MRONJ, a cutting-grinding technique, using non-decalcified, MMA-
embedded material stained with Giemsa-eosin d a special stain
often used in bone histology d may be more effective in high-
lighting histological changes compared with the use of standard
HE-staining of paraffin-embedded material.
The most obvious histopathological change found in this animal
model was active osteomyelitis, along with bacterial infection, a
Table 4
Clinically relevant parameters chosen to devise the scoring system.
Clinical Radiological Histological
Exposed necrotic bone 1e10 Healing of extraction socket Presence/absence High-grade gingival ulceration with orally exposed bone 3e5
Fistula/abscess 0e5 Peri/endosteal reaction 0e5 Demineralization of extracellular matrix of denuded bone areas 0e5
Purulent discharge 1e3 Soft tissue swelling 0e5 Osteonecrosis (foci of n > 5 empty lacunae) 0e5
Soft tissue swelling 1e3 Apparent density of trabecular
bone under extraction site
HU value Bacterial osteomyelitis 0e5
Gingivitis 1e3 Empyema Presence/absence Empyema 0e5
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finding also characteristic for MRONJ in human patients (Lesclous
et al., 2009; Ji et al., 2012). Infections with Actinomyces spp. are
often identified using bacteriological analysis of biopsy samples
(Chiandussi et al., 2006). This feature was also found in this animal
model, where sulfur granules in the maxillary and mandibular em-
pyema were described, this morphologically characterizing the
involvement of Actinomyces spp. Currently, it is unclear whether
these bacteria are a causal pathogen or only an accompanying feature
of otherwiseaffectedbone stock. In this context, it is important tonote
that these non-obligatory-pathogenic bacteria are commonly found
in the oral fauna of pigs (and humans), can enter the bone tissue via
open wounds (e.g. after surgical tooth extraction) or via ubiquitous,
small, epithelial changes in the gingiva, and may therefore represent
only concomitant infections. Both incomplete gingival coverage of the
tooth extraction sites aswell asmultifocal gingivitis and periodontitis
(Kos, 2014), along with microscopic evidence of food material (all
found in this model), facilitate such bacterial inoculation.
The low numbers of osteoblasts lining the bone trabeculi rep-
resented a marked affection of bone formation; this was only
recorded in ZOL-treated animals (groups 1 and 2). It is important to
note that this finding was not only recorded at the tooth extraction
sites, but also in the contralateral areas without tooth extraction,
which may give important clues regarding the principal patho-
logical importance of BP treatment in inducing MRONJ. Along with
the pronounced osteoclastic bone resorption d more pronounced
in animals in groups 1 and 2 d BP treatment caused a marked
reduction in bone density. Furthermore, the presence of empty
osteocytic lacunae d the characteristic microscopic feature of
osteonecrosis d was more pronounced at the extraction sites in
ZOL-treated animals (group 1 and 2). On the contralateral sides
without tooth extraction the severity was comparable with the
non-ZOL-treated animals of group 3, where low-grade osteonec-
rosis could also be observed. Finally, osteolysis of low to moderate
severity, along with exposure of denuded bone to the oral cavity,
was exclusively found in animals of group 2. By applying fluores-
cence illumination to histological sections, the osteolytic areas
could be easily identified due to the prior exposure of the animal to
doxycycline. This feature can also be used in clinical characteriza-
tion and therapy when combined with tetracycline, a commonly
used antibiotic (Pautke et al., 2010, 2011).
The osteolysis was consistent in the lower jaw (all six mandib-
ular extraction sites were affected). The ZOL-treated animals of
group 1 d without tooth extraction d did not show this change.
Therefore, the destruction of extracellular matrix at the denuded
bone surface is the sole microscopic hallmark of MRONJ-like
changes in this animal model. This raises the important issue of
BP treatment in the presence of large, iatrogenic wounds. Animals
in group 3, which were not treated with BP but had large open
wounds after tooth extraction, only had low-grade inflammation of
the gingiva, and showed no deeper indications, such as osteomy-
elitis, empyema, or osteolysis of exposed bone.
5. Conclusion
This study proposes and describes clinical, radiological, and
histological parameters that can be used for scoring of MRONJ in a
minipig model. The clinical parameters include exposed, necrotic
bone, fistula formation, and inflammation. Radiological parame-
ters include lack of extraction socket healing, decrease in atten-
uation in bone beneath the extraction site, and periosteal
reaction. Histological parameters include osteolysis of extracel-
lular bone matrix and bone denudation. These parameters make
up a valid tool for designing and assessing MRONJ therapy and
prevention studies in minipig models. The system could be used
in other large animal models, such as sheep (Voss et al., 2016), but
this would require further validation. The radiological parameters
indicated may also be of value in the clinical diagnosis and staging
of MRONJ patients.
Further investigation of changes in animal models may help to
answer open questions regarding the pathogenesis of MRONJ, as
well as its prevention or treatment.
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